“GCs are running ahead of check, and that's very much consistent with our experience as you're putting in new value programs, you will see check run ahead of GCs.”

In context

“helpful. Thank you. Chris Kempczinski: Sure. I'll kind of just hit some high-level comments, and then as always, I'll let Ian give the details. You know, in the US, we were seeing it, as you know, in early October, we were seeing strong performance in the US with both good check as well as positive GCs. And then, of course, we had the unfortunate E. coli incident. As you think about how then the quarter started to play out, we kind of hit our nadir in, I'd say, early November, and then we saw sequential improvement through the balance of the quarter, which has now continued into Q1. But what you're seeing is you're seeing that we are driving GCs and stealing share from a GC standpoint. But not surprisingly, particularly now as we're into Q1 and we're launching a broader McValue platform, GCs are running ahead of check, and that's very much consistent with our experience as you're putting in new value programs, you will see check run ahead of GCs. I think Joe has talked about that in the past. And then as you get that sort of bedded down, and you introduce food news and other things on top of that, you get the one-two punch of check plus GC growth. So that's what we're expecting in the US. From IOM, you're right to acknowledge that we're seeing improving trends there. But it really is almost on a market-by-market basis there. So we've talked about for basically about a year some of the opportunities that we had in France. I've been very pleased to see how that French business has continued to improve their performance, and that's continuing into Q1. So we feel good about France. We feel good about Canada. We continue to outperform in Germany. We continue to outperform in Italy. Our opportunities in IOM, the two markets that we are”